WO1997020938A3 - Cellules avec recepteur hybride et gene de synthese ainsi commande, et utilisation de ces cellules en therapie genique - Google Patents

Cellules avec recepteur hybride et gene de synthese ainsi commande, et utilisation de ces cellules en therapie genique Download PDF

Info

Publication number
WO1997020938A3
WO1997020938A3 PCT/DE1996/002334 DE9602334W WO9720938A3 WO 1997020938 A3 WO1997020938 A3 WO 1997020938A3 DE 9602334 W DE9602334 W DE 9602334W WO 9720938 A3 WO9720938 A3 WO 9720938A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
hybrid receptor
receptor
cell
gene
Prior art date
Application number
PCT/DE1996/002334
Other languages
German (de)
English (en)
Other versions
WO1997020938A2 (fr
Inventor
Roland Mertelsmann
Peter Kulmburg
Felicia Rosenthal
Original Assignee
Univ Ludwigs Albert
Roland Mertelsmann
Peter Kulmburg
Felicia Rosenthal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ludwigs Albert, Roland Mertelsmann, Peter Kulmburg, Felicia Rosenthal filed Critical Univ Ludwigs Albert
Priority to AU18686/97A priority Critical patent/AU1868697A/en
Publication of WO1997020938A2 publication Critical patent/WO1997020938A2/fr
Publication of WO1997020938A3 publication Critical patent/WO1997020938A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne des cellules comportant un récepteur hybride dont une première partie, localisée sur le côté extérieur de la cellule, est spécifique d'une certaine molécule signal et une seconde partie, localisée à l'intérieur de la cellule et issue d'un autre récepteur, peut déclencher un signal à l'intérieur de la cellule. La cellule contient au moins un autre gène de synthèse qui présente une zone de commande pouvant interagir avec le signal émis par le récepteur hybride et ainsi commander l'expression d'un transgène lié à la zone de commande. L'invention concerne également un procédé de production de ces cellules et l'utilisation de ces cellules en thérapie génique.
PCT/DE1996/002334 1995-12-05 1996-12-03 Cellules avec recepteur hybride et gene de synthese ainsi commande, et utilisation de ces cellules en therapie genique WO1997020938A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU18686/97A AU1868697A (en) 1995-12-05 1996-12-03 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19545351.4 1995-12-05
DE1995145351 DE19545351C1 (de) 1995-12-05 1995-12-05 Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie

Publications (2)

Publication Number Publication Date
WO1997020938A2 WO1997020938A2 (fr) 1997-06-12
WO1997020938A3 true WO1997020938A3 (fr) 2002-02-14

Family

ID=7779244

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/002334 WO1997020938A2 (fr) 1995-12-05 1996-12-03 Cellules avec recepteur hybride et gene de synthese ainsi commande, et utilisation de ces cellules en therapie genique

Country Status (3)

Country Link
AU (1) AU1868697A (fr)
DE (1) DE19545351C1 (fr)
WO (1) WO1997020938A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277368B1 (en) 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
IL136511A0 (en) 2000-06-01 2001-06-14 Gavish Galilee Bio Appl Ltd Genetically engineered mhc molecules

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018317A1 (fr) * 1993-02-12 1994-08-18 The Board Of Trustees Of The Leland Stanford Junior University Transcription regulee de genes cibles et d'autres evenements biologiques
WO1995020670A1 (fr) * 1994-01-28 1995-08-03 Targeted Genetics Corporation Elements regulateurs transcriptionnels de cd 69

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018317A1 (fr) * 1993-02-12 1994-08-18 The Board Of Trustees Of The Leland Stanford Junior University Transcription regulee de genes cibles et d'autres evenements biologiques
WO1995020670A1 (fr) * 1994-01-28 1995-08-03 Targeted Genetics Corporation Elements regulateurs transcriptionnels de cd 69

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
D. MORITZ ET AL: "Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 91, May 1994 (1994-05-01), WASHINGTON US, pages 4318 - 4322, XP000647482 *
DATABASE MEDLINE, Accession no 95102497 *
S. ZIEGLER ET AL: "The activation antigen CD69", STEM CELLS, vol. 12, no. 5, September 1994 (1994-09-01), pages 456 - 465 *
T. BROCKER ET AL: "New simplified molecular design for functional T cell receptor", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 23, 1993, pages 1435 - 1439, XP000673214 *

Also Published As

Publication number Publication date
WO1997020938A2 (fr) 1997-06-12
AU1868697A (en) 1997-06-27
DE19545351C1 (de) 1997-07-31

Similar Documents

Publication Publication Date Title
WO1998012311A3 (fr) Utilisation d'un virus a adn non mammalien pour l'expression d'un gene exogene dans une cellule mammalienne
HK1017903A1 (en) Process for controlling sialylation of proteins produced by mammalian cell culture.
EP0844888A4 (fr) Vecteurs viraux specifiques a des tissus
HUP0000317A3 (en) Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
AU2001278797A1 (en) Expression vector using for animal cell
WO1998042851A8 (fr) Plantes presentant une croissance modifiee
WO2002029075A3 (fr) Systeme de regulation de multiples genes inductibles
WO1998045456A8 (fr) Sequences d'adn codant pour une 2-desoxyglucose-6-phosphate (2-dog-6-p) phosphatase et servant de marqueur de selection chez les vegetaux
CA2133203A1 (fr) Facteur viii humain/porcin hybride
EP0831903A4 (fr) Facteur de croissance des tissus conjonctifs
MX9705039A (es) Genes y proteinas de muerte celular programada.
WO1998028317A3 (fr) Synthese chimique d'analogues de nucleosides et leur incorporation dans des polynucleotides
ZA971158B (en) Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs.
AU5539898A (en) Nucleic acid construct for the cell cycle regulated expression of structural genes
CA2306449A1 (fr) Generation rapide de lignees cellulaires mammiferes stables produisant des niveaux eleves de proteines recombinantes
AU2162699A (en) Method for grafting lignin, polymerizates produced according to the method and the utilization thereof
WO1998024906A3 (fr) Genes isoles de monocytes de mammifere et reactifs associes
AU6415496A (en) Encapsulated cells producing viral particles
WO1997020045A3 (fr) Nouveau recepteur purinergique p2u2
WO2000052136A3 (fr) Enzymes de glycosylation humaines
AU2667995A (en) Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells
WO1999040205A8 (fr) Glycosyltransferase et adn la codant
WO1997020938A3 (fr) Cellules avec recepteur hybride et gene de synthese ainsi commande, et utilisation de ces cellules en therapie genique
EP0068375A3 (fr) Techniques d'ADN recombinant pour la production de relaxine
AU1814995A (en) Galanin receptor, nucleic acids, transformed cells and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97520871

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE